The clinical utility of genetic risk variants in type 2 diabetes
Background: Type 2 diabetes is one of the first success stories in the application of genome-wide linkage and association studies to find genetic variants contributing to its risk. Objective: Are the genetic markers found so far useful in predicting which individuals are more likely to develop type...
Gespeichert in:
Veröffentlicht in: | Expert opinion on medical diagnostics 2008-08, Vol.2 (8), p.991-1002 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Type 2 diabetes is one of the first success stories in the application of genome-wide linkage and association studies to find genetic variants contributing to its risk. Objective: Are the genetic markers found so far useful in predicting which individuals are more likely to develop type 2 diabetes? Can they find which patients with prediabetes are more likely to convert to type 2 diabetes and therefore may benefit the most from lifestyle or pharmacologic prevention strategies? Methods: The literature pertaining to the discovery and replications of genes contributing to type 2 diabetes was focused on. Results/conclusion: Substantial risk for type 2 diabetes is represented by the top 8 genes, including TCF7L2, and in certain circumstances may be useful for prevention strategies targeted to those with highest risk. |
---|---|
ISSN: | 1753-0059 1753-0067 |
DOI: | 10.1517/17530059.2.8.991 |